Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) is established in 1994. As a Leading Healthcare Group in China, Fosun Pharma’s business covers all key segments of healthcare industry including Pharmaceutical Manufacturing and R&D, healthcare services, Medical Device and Medical Diagnosis as well as pharmaceutical Distribution & Retail.
Tridem Pharma, Fosun Pharma’s business unit for Africa and Middle East, has built a comprehensive pharmaceutical supply chain to cover nearly 90% of Africa and Middle East region.
In 1986, TRIDEM Pharma started building a strong track record in the market and out in the field. Acting as an expert interface between the pharmaceutical industry and the Africa and Middle East market (e.g. health authorities, wholesalers, prescribers and pharmacists), we dedicate ourselves to source supply good quality and affordable pharmaceutical and healthcare products from all over the world for people in the region.
As a result of its second-to-none reputation, image of excellence and unicity of value proposal, we have a loyal and longstanding client portfolio, continuously reinforced by new clients eager to penetrate the Africa and Middle East market. We believe, our diverse and complementary core competencies will bring a long-term success to our clients.